These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1873 related articles for article (PubMed ID: 16003449)

  • 1. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.
    Khan NA; McAlister FA; Rabkin SW; Padwal R; Feldman RD; Campbell NR; Leiter LA; Lewanczuk RZ; Schiffrin EL; Hill MD; Arnold M; Moe G; Campbell TS; Herbert C; Milot A; Stone JA; Burgess E; Hemmelgarn B; Jones C; Larochelle P; Ogilvie RI; Houlden R; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; Dechamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Tobe S; Touyz RM;
    Can J Cardiol; 2006 May; 22(7):583-93. PubMed ID: 16755313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Khan NA; Hemmelgarn B; Padwal R; Larochelle P; Mahon JL; Lewanczuk RZ; McAlister FA; Rabkin SW; Hill MD; Feldman RD; Schiffrin EL; Campbell NR; Logan AG; Arnold M; Moe G; Campbell TS; Milot A; Stone JA; Jones C; Leiter LA; Ogilvie RI; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; Burns KD; Ruzicka M; deChamplain J; Pylypchuk G; Gledhill N; Petrella R; Boulanger JM; Trudeau L; Hegele RA; Woo V; McFarlane P; Touyz RM; Tobe SW;
    Can J Cardiol; 2007 May; 23(7):539-50. PubMed ID: 17534460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Hackam DG; Khan NA; Hemmelgarn BR; Rabkin SW; Touyz RM; Campbell NR; Padwal R; Campbell TS; Lindsay MP; Hill MD; Quinn RR; Mahon JL; Herman RJ; Schiffrin EL; Ruzicka M; Larochelle P; Feldman RD; Lebel M; Poirier L; Arnold JM; Moe GW; Howlett JG; Trudeau L; Bacon SL; Petrella RJ; Milot A; Stone JA; Drouin D; Boulanger JM; Sharma M; Hamet P; Fodor G; Dresser GK; Carruthers SG; Pylypchuk G; Burgess ED; Burns KD; Vallée M; Prasad GV; Gilbert RE; Leiter LA; Jones C; Ogilvie RI; Woo V; McFarlane PA; Hegele RA; Tobe SW;
    Can J Cardiol; 2010 May; 26(5):249-58. PubMed ID: 20485689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.
    Khan NA; Hemmelgarn B; Herman RJ; Bell CM; Mahon JL; Leiter LA; Rabkin SW; Hill MD; Padwal R; Touyz RM; Larochelle P; Feldman RD; Schiffrin EL; Campbell NR; Moe G; Prasad R; Arnold MO; Campbell TS; Milot A; Stone JA; Jones C; Ogilvie RI; Hamet P; Fodor G; Carruthers G; Burns KD; Ruzicka M; DeChamplain J; Pylypchuk G; Petrella R; Boulanger JM; Trudeau L; Hegele RA; Woo V; McFarlane P; Vallée M; Howlett J; Bacon SL; Lindsay P; Gilbert RE; Lewanczuk RZ; Tobe S;
    Can J Cardiol; 2009 May; 25(5):287-98. PubMed ID: 19417859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Khan NA; Hemmelgarn B; Herman RJ; Rabkin SW; McAlister FA; Bell CM; Touyz RM; Padwal R; Leiter LA; Mahon JL; Hill MD; Larochelle P; Feldman RD; Schiffrin EL; Campbell NR; Arnold MO; Moe G; Campbell TS; Milot A; Stone JA; Jones C; Ogilvie RI; Hamet P; Fodor G; Carruthers G; Burns KD; Ruzicka M; dechamplain J; Pylypchuk G; Petrella R; Boulanger JM; Trudeau L; Hegele RA; Woo V; McFarlane P; Vallée M; Howlett J; Katzmarzyk P; Tobe S; Lewanczuk RZ;
    Can J Cardiol; 2008 Jun; 24(6):465-75. PubMed ID: 18548143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.
    McAlister FA; Levine M; Zarnke KB; Campbell N; Lewanczuk R; Leenen F; Rabkin S; Wright JM; Stone J; Feldman RD; Lebel M; Honos G; Fodor G; Burgess E; Tobe S; Hamet P; Herman R; Irvine J; Culleton B; Petrella R; Touyz R;
    Can J Cardiol; 2001 May; 17(5):543-59. PubMed ID: 11381277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy.
    McAlister FA; Zarnke KB; Campbell NR; Feldman RD; Levine M; Mahon J; Grover SA; Lewanczuk R; Leenen F; Tobe S; Lebel M; Stone J; Schiffrin EL; Rabkin SW; Ogilvie RI; Larochelle P; Jones C; Honos G; Fodor G; Burgess E; Hamet P; Herman R; Irvine J; Culleton B; Wright JM;
    Can J Cardiol; 2002 Jun; 18(6):625-41. PubMed ID: 12107420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2004 Canadian recommendations for the management of hypertension: Part III--Lifestyle modifications to prevent and control hypertension.
    Touyz RM; Campbell N; Logan A; Gledhill N; Petrella R; Padwal R;
    Can J Cardiol; 2004 Jan; 20(1):55-9. PubMed ID: 14968143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR; Burgess E; Choi BC; Taylor G; Wilson E; Cléroux J; Fodor JG; Leiter LA; Spence D
    CMAJ; 1999 May; 160(9 Suppl):S1-6. PubMed ID: 10333847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
    Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
    Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Fodor JG; Whitmore B; Leenen F; Larochelle P
    CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.
    Hemmelgarn BR; McAllister FA; Myers MG; McKay DW; Bolli P; Abbott C; Schiffrin EL; Grover S; Honos G; Lebel M; Mann K; Wilson T; Penner B; Tremblay G; Tobe SW; Feldman RD;
    Can J Cardiol; 2005 Jun; 21(8):645-56. PubMed ID: 16003448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifestyle modifications to prevent and control hypertension. 3. Recommendations on alcohol consumption. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR; Ashley MJ; Carruthers SG; Lacourcière Y; McKay DW
    CMAJ; 1999 May; 160(9 Suppl):S13-20. PubMed ID: 10333849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle modifications to prevent and control hypertension. 4. Recommendations on physical exercise training. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Cléroux J; Feldman RD; Petrella RJ
    CMAJ; 1999 May; 160(9 Suppl):S21-8. PubMed ID: 10333850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Leiter LA; Abbott D; Campbell NR; Mendelson R; Ogilvie RI; Chockalingam A
    CMAJ; 1999 May; 160(9 Suppl):S7-12. PubMed ID: 10333848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle modifications to prevent and control hypertension. 7. Recommendations on stress management. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Spence JD; Barnett PA; Linden W; Ramsden V; Taenzer P
    CMAJ; 1999 May; 160(9 Suppl):S46-50. PubMed ID: 10333853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.
    Zarnke KB; McAlister FA; Campbell NR; Levine M; Schiffrin EL; Grover S; McKay DW; Myers MG; Wilson TW; Rabkin SW; Feldman RD; Burgess E; Bolli P; Honos G; Lebel M; Mann K; Abbott C; Tobe S; Petrella R; Touyz RM;
    Can J Cardiol; 2002 Jun; 18(6):604-24. PubMed ID: 12107419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 94.